Showing 13,681–13,700 of 17,974 drug recalls
Drug Recall
Terminated
Historical record Class II
Lisinopril Tablets USP, 10 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-929-01), B) 500 Count Bottles (NDC: 64679-929-05), and C) 1000 Count Bottles (NDC: 64679-929-06), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Lisinopril Tablets USP, 5 mg Tablets,Packaged in A) 100 Count Bottles (NDC: 64679-928-01), B) 500 Count Bottles (NDC: 64679-928-05), and C) 1000 Count Bottles (NDC: 64679-928-06), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Amlodipine Besylate Tablets, 10 mg Tablets, Packaged as A) 90 Count Bottles (NDC: 64679-423-01) and B) 1000 Count Bottles (NDC: 64679-423-02, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Amlodipine Besylate Tablets, 5 mg Tablets, Packaged as A) 90 Count Bottles (NDC: 64679-422-01) and B) 1000 Count Bottles (NDC: 64679-422-02), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Zonisamide Capsules, 100 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0990-01. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Tamsulosin Hydrochloride Capsules, USP*, 0.4 mg Capsules, Packaged in A) 100 Count Bottles (NDC: 64679-516-02) and B) 500 Count Bottles (NDC: 64679-516-03), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Metoprolol Succinate Extended-Release Tablets, USP, 200 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0737-02) and B) 500 Count Bottles (NDC: 64679-0737-03), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA . by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, For Repackaging Only, Packaged in 4500 Count Pouches, Over the Counter. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-140-00. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Famotodine Tablets, USP, 40 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-937-01), B) 100 Count Bottles (NDC: 64679-937-02), and C) 1000 Count Bottles (NDC: 64679-937-03), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Clarithromycin Tablets, USP, 500 mg Tablets, 60 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-949-01. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Azithromycin Tablets, USP, 250 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-0961-01), B) 3,500 Count Pouches (NDC: 64679-961-08), and C) 3 x 6 Tablet Card Cartons (NDC: 64679-961-05), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Zolpidem Tartrate Tablets, 5 mg Tablets, CIV, Packaged in 100 Tablet Bottles, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-714-01. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Extended Phenytoin Sodium Capsules, USP, 100 mg Capsules, Packaged as A) 100 Count Bottles (NDC: 64679-720-01) and B) 1000 Count Bottles (NDC: 64679-720-02), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Lamotrigine Extended-Release Tablets, 25 mg Tablets, 30 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-271-01. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Lisinopril Tablets USP, 2.5 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-927-01) and B) 500 Count Bottles (NDC: 64679-927-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class II
Amlodipine Besylate Tablets, 2.5 mg Tablets, Packaged in 90 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-421-01. by Wockhardt Usa Inc.
Reason
CGMP Deviations: Firm did not adequately investigate customer complaints. Recall initiated
April 22, 2015 Reported by FDA
July 29, 2015 Distribution
U.S. Nationwide including Puerto Rico.
View recall →
Drug Recall
Ongoing
Historical record Class II
KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49 by Hospira Inc.
Reason
Crystallization; identified as calcium salt of Ketorolac Recall initiated
June 30, 2015 Reported by FDA
July 22, 2015 Distribution
Nationwide, Puerto Rico, Guam, Canada and Singapore
View recall →
Drug Recall
Ongoing
Historical record Class II
KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49 by Hospira Inc.
Reason
Crystallization; identified as calcium salt of Ketorolac Recall initiated
June 30, 2015 Reported by FDA
July 22, 2015 Distribution
Nationwide, Puerto Rico, Guam, Canada and Singapore
View recall →
Drug Recall
Terminated
Historical record Class II
0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68 by Hospira Inc.
Reason
Lack of assurance of sterility: Potential channel leaks near the threaded vial port. Recall initiated
July 2, 2015 Reported by FDA
July 22, 2015 Distribution
United States
View recall →
Drug Recall
Terminated
Historical record Class III
HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL by Qualitest Pharmaceuticals
Reason
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable Recall initiated
June 29, 2015 Reported by FDA
July 22, 2015 Distribution
Nationwide
View recall →
Data last updated: September 28, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .